Solid phase synthesis and biological evaluation of probestin as an angiogenesis inhibitor.

Bioorg Med Chem Lett

Department of Pharmaceutical Sciences, College of Pharmacy, The University of Oklahoma Health Sciences Center, 1110 N. Stonewall Avenue, Room 301, Oklahoma City, OK 73117, USA.

Published: June 2013

Probestin is a potent aminopeptidase N (APN) inhibitor originally isolated from the bacterial culture broth. Here, we report probestin synthesis by solid phase peptide synthesis (SPPS) method and evaluated its activity to inhibit angiogenesis using a chicken embryo chorioallantoic membrane (CAM) assay and a CAM tumor xenograft model. Results from these studies demonstrate that probestin inhibits the angiogenic activity and tumor growth.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172075PMC
http://dx.doi.org/10.1016/j.bmcl.2013.04.031DOI Listing

Publication Analysis

Top Keywords

solid phase
8
phase synthesis
4
synthesis biological
4
biological evaluation
4
probestin
4
evaluation probestin
4
probestin angiogenesis
4
angiogenesis inhibitor
4
inhibitor probestin
4
probestin potent
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!